BioSpace News Archive

In documents prepared for the meeting, the vaccine demonstrated 90.7% effectiveness for the children in this age group.

Scientists are scrambling to find the cause for the sudden spike in human cases of avian influenza A (H5N6) in China to 21 this year, from only five in 2020.

Seattle-based Mozart Therapeutics closed on a $55 million Series A financing round. The company focuses on developing treatments for celiac disease and other immune-related conditions.

On Tuesday morning, Provention Bio announced positive interim results from its Phase I PROVENT study of PRV-101.

Hospital for Special Surgery has received a landmark contribution from philanthropists Leonard A. Lauder and Ronald S. Lauder to establish the Lauder Family Spine Center.

Todos Medical, Ltd. today announced that its CEO Gerald Commissiong will be presenting a corporate overview at the Benzinga Global Small Cap Conference which is being held virtually on October 27-28, 2021.

Centinel Spine®, LLC, today announced the recent publication of a research study on its STALIF C-Ti® product in the Journal of Surgery & Anesthesia Research: “Preliminary 12-Month Safety and Efficacy Outcomes for the Treatment of Cervical Radiculopathy and Myelopathy with the Stalif-C Integrated Interbody Fusion Device.”

The American Society for Preventive Cardiology (ASPC) has recently published a Clinical Practice Statement in the American Journal of Preventive Cardiology: Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials.

CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development, and commercialization of transformative therapies, announced that it has dosed the first patient in the CAN008 Phase 2 clinical trial to treat glioblastoma multiforme in Mainland China.

Kainomyx, Inc., founded in September 2019 and financed with $7.5M in May 2020, announced a new round of funding of $7.97M to advance its programs in malaria therapeutics, malaria diagnostics and therapeutics for other parasitic diseases.